- Home
- AGO vs CORT Comparison
AGO vs CORT Comparison
Compare AGO & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGO | CORT |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2003 | 2001 |
Fundamental Metrics
Financial Performance| Metric | AGO | CORT |
|---|---|---|
| Price | $83.16 | $43.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $101.67 | $96.50 |
| AVG Volume (30 Days) | 250.8K | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.63% | N/A |
| EPS Growth | ★ 49.34 | N/A |
| EPS | ★ 10.26 | 0.82 |
| Revenue | ★ $1,110,000,000.00 | $761,407,000.00 |
| Revenue This Year | $3.06 | $26.08 |
| Revenue Next Year | N/A | $31.04 |
| P/E Ratio | ★ $8.15 | $53.49 |
| Revenue Growth | ★ 27.29 | 12.79 |
| 52 Week Low | $78.77 | $28.66 |
| 52 Week High | $92.40 | $91.00 |
Technical Indicators
Market Signals| Indicator | AGO | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 66.79 |
| Support Level | $82.60 | $32.95 |
| Resistance Level | $83.90 | $47.06 |
| Average True Range (ATR) | 1.46 | 1.69 |
| MACD | 0.37 | 0.48 |
| Stochastic Oscillator | 76.34 | 93.54 |
Price Performance
Historical ComparisonAbout AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.